中国药物警戒 ›› 2010, Vol. 7 ›› Issue (6): 327-328.

• 临床研究 • 上一篇    下一篇

排石颗粒与枸橼酸氢钾钠颗粒治疗泌尿系尿酸结石的药物经济学分析

李明艳, 张翠华   

  1. 广西医科大学第四附属医院,广西 柳州 545005
  • 收稿日期:2016-02-22 修回日期:2016-02-22 出版日期:2010-06-08 发布日期:2016-02-22
  • 作者简介:李明艳,女,主管药师,药物制剂检验及临床药学。

Pharmacoeconomic Analysis of Pai Shi Ke Li and Potassium Sodium Hydrogen Citrate Healing Urinary System Calculus

LI Ming-yan, ZHANG Cui-hua   

  1. The 4th Affiliated Hospital of Guangxi Medical University, Guangxi Liuzhou 545005, China
  • Received:2016-02-22 Revised:2016-02-22 Online:2010-06-08 Published:2016-02-22

PDF (PC)

967

摘要： 目的 比较排石颗粒和枸橼酸钾钠颗粒治疗泌尿系尿酸结石的成本与疗效。方法 98例泌尿系结石患者随机分为2组,分别给予排石颗粒和枸橼酸钾钠颗粒治疗30天,观察各组疗效及不良反应,运用药物经济学中成本-效果分析进行评价。结果 排石颗粒组总有效率为76.9%,枸橼酸氢钾钠颗粒组总有效率为78.3%。两者疗效无显著性差异。两组的成本-效果分析比分别为7.06,20.46。结论 从药物经济学角度来说,排石颗粒治疗泌尿系结石是更好的选择。

关键词: 排石颗粒, 枸橼酸氢钾钠颗粒, 药物经济学

Abstract: Objective To compare the cost-effect of Pai Shi Ke Li and Potassium Sodium Hydrogen Citrate healing urinary system uric acid calculus. Methods 98 patients who suffered from urinary system calculus were randomly divided into two groups, administrated with Pai Shi Ke Li or Potassium Sodium Hydrogen Citrate,which was evaluated by cost-effect analysis of pharmacoeconomic. Results The effective rate of the Pai Shi Ke Li group was 76.9%,and the effective rate of Potassium Sodium Hydrogen Citrate was 78.3%. The rates of cost-effect were respectively 7.06 and 20.46. Conclusion Pai shi ke li is the better choice for urinary system calculus from pharmcoeconomic point of view.

Key words: Pai Shi Ke Li, Potassium Sodium Hydrogen Citrate, pharmcoeconomic

中图分类号: